Canadian National Railway Company
CNI NYSEIndustrials ★★★★★Latest Earnings
Date
Jul 24, 2026
ET
EPS Est.
1.39
EPS Actual
1.50
Revenue Est.
$3.26B
Revenue Actual
$3.35B
Next Earnings Report
Date
Oct 30, 2026 · Fri
Time
Time TBD
Fiscal Period
FY2026 Q3
EPS Est.
1.49
Revenue Est.
$3.33B
Company Overview
Canadian National Railway Company (ticker CNI) is listed on NYSE with a market cap of about $78.54B. Its next earnings report (FY2026 Q3) is expected on Oct 30, 2026 (ET), Time TBD, with consensus EPS of 1.49. In the last 15 reported quarters, EPS beat consensus estimates 7 times.
Actual EPS TrendRecently15Term · Jan 24, 2023 → Jul 24, 2026
Jan 24, 2023Range: 1.26 ~ 1.55Jul 24, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 24, 2026 | -- | 1.39 | 1.50 | $3.26B | $3.35B |
| Apr 29, 2026 | -- | 1.31 | 1.31 | $3.15B | $3.15B |
| Jan 30, 2026 | -- | 1.43 | 1.49 | $3.25B | $3.25B |
| Oct 31, 2025 | -- | 1.28 | 1.33 | $4.43B | $2.14B |
| Jul 22, 2025 | -- | 1.37 | 1.35 | $4.17B | $3.14B |
| May 1, 2025 | -- | 1.26 | 1.29 | $4.36B | $3.09B |
| Jan 30, 2025 | -- | 1.37 | 1.30 | $4.37B | $3.03B |
| Oct 22, 2024 | -- | 1.28 | 1.26 | $2.98B | $3.03B |
| Jul 23, 2024 | -- | 1.41 | 1.35 | $3.21B | $3.17B |
| Apr 23, 2024 | -- | 1.27 | 1.28 | $3.11B | $3.04B |
| Jan 23, 2024 | -- | 1.46 | 1.48 | $3.25B | $3.37B |
| Oct 24, 2023 | -- | 1.29 | 1.26 | $3.06B | $2.94B |
| Jul 25, 2023 | -- | 1.37 | 1.31 | $3.17B | $3.06B |
| Apr 24, 2023 | -- | 1.26 | 1.35 | $3.16B | $3.19B |
| Jan 24, 2023 | -- | 1.56 | 1.55 | $3.31B | $3.39B |
Original Filings (SEC)
6-K2026-07-24 ↗
6-K2026-07-23 ↗
6-K2026-07-23 ↗
6-K2026-05-08 ↗
6-K2026-05-01 ↗
6-K2026-05-01 ↗
6-K2026-04-29 ↗
6-K2026-04-29 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
